Company logo

RSLS - ReShape Lifesciences Inc.

NASDAQ -> Healthcare -> Medical Devices
San Clemente, United States
Type: Equity

RSLS price evolution
RSLS
(in millions $) 30 Oct 2022 30 Jul 2022 1 May 2022 31 Jan 2022
Current assets
Cash
Short term investments
Net receivables $2.45 $2.41 $2.81
Inventory $4.23 $4 $3
Total current assets $19.49 $23.63 $30.25
Long term investments
Property, plant & equipment $1.23 $1.9 $1.72
Goodwill & intangible assets
Total noncurrent assets
Total investments
Total assets $41.92 $47.27 $54.26
Current liabilities
Accounts payable $3.47
Deferred revenue
Short long term debt
Total current liabilities $9.19 $8.15 $7.33
Long term debt
Total noncurrent liabilities
Total debt
Total liabilities $9.56 $8.64 $8.19
Shareholders' equity
Retained earnings -$594.55 -$584.98 -$576.76
Other shareholder equity -$0.07 -$0.07 -$0.09
Total shareholder equity
(in millions $) 31 Jan 2022 30 Jan 2021 30 Jan 2020 30 Jan 2019
Current assets
Cash $3.9
Short term investments
Net receivables $2.81 $2.62 $0.28 $0.88
Inventory $3 $2.24 $1.94 $1.58
Total current assets $30.25 $7.83 $18.23 $28.65
Long term investments
Property, plant & equipment $1.72 $0.96 $2.16 $1.74
Goodwill & intangible assets
Total noncurrent assets $2.78
Total investments
Total assets $54.26 $10.62 $20.39 $30.39
Current liabilities
Accounts payable $3.47 $0.61 $0.65 $1.16
Deferred revenue
Short long term debt
Total current liabilities $7.33 $5.05 $3.98 $17.23
Long term debt $0.43
Total noncurrent liabilities $0.91
Total debt
Total liabilities $8.19 $5.95 $4.54 $17.28
Shareholders' equity
Retained earnings -$576.76 -$184.76 -$172.43 -$148.75
Other shareholder equity -$0.09 -$0.12
Total shareholder equity